# Falcon's Beyond Global, Inc.: financial statements, quarterly

FBYD · Nasdaq · CIK 1937987 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fbyd.md) · [Financials](/companies/fbyd/financials.md) · [Filings](/companies/fbyd/filings.md) · [Insiders](/companies/fbyd/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fbyd/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1.6](/filings/0001213900-24-098550.md) | [2.1 d](/filings/0000950170-25-049918.md) | [1.5](/filings/0000950170-25-072750.md) | [1.8](/filings/0000950170-25-108424.md) | [2.1](/filings/0001193125-25-281562.md) | [1.4 d](/filings/0001193125-26-131874.md) | [1.7](/filings/0001193125-26-224203.md) | [2.5](/filings/0001193125-26-347885.md) | [4.1](/filings/0001193125-25-281562.md) | [6.6 d](/filings/0001193125-26-131874.md) | [5.4](/filings/0001193125-26-224203.md) | [5.6](/filings/0001193125-26-347885.md) |
| Research and development | $m | [0.3](/filings/0001213900-24-098550.md) | [(0.0) d](/filings/0000950170-25-049918.md) | [0.0](/filings/0000950170-25-072750.md) | [0.0](/filings/0000950170-25-108424.md) | [0.0](/filings/0001213900-24-098550.md) | [0.1 d](/filings/0000950170-25-049918.md) | [0.1](/filings/0001193125-26-224203.md) | [0.1](/filings/0001193125-26-347885.md) | not reported | not reported | [0.0](/filings/0001193125-26-224203.md) | [0.0](/filings/0001193125-26-347885.md) |
| Selling, general and administrative | $m | [4.3](/filings/0001213900-24-098550.md) | [4.8 d](/filings/0000950170-25-049918.md) | [6.8](/filings/0000950170-25-072750.md) | [5.3](/filings/0000950170-25-108424.md) | [4.5](/filings/0001193125-25-281562.md) | [5.8 d](/filings/0001193125-26-131874.md) | [6.3](/filings/0001193125-26-224203.md) | [6.6](/filings/0001193125-26-347885.md) | [6.2](/filings/0001193125-25-281562.md) | [6.4 d](/filings/0001193125-26-131874.md) | [7.7](/filings/0001193125-26-224203.md) | [7.7](/filings/0001193125-26-347885.md) |
| Operating income | $m | [(20.4)](/filings/0001213900-24-098550.md) | [(20.3) d](/filings/0000950170-25-049918.md) | [(5.3)](/filings/0000950170-25-072750.md) | [(3.5)](/filings/0000950170-25-108424.md) | [(2.5)](/filings/0001193125-25-281562.md) | [(4.6) d](/filings/0001193125-26-131874.md) | [(6.3)](/filings/0001193125-26-224203.md) | [(1.4)](/filings/0001193125-26-347885.md) | [(3.7)](/filings/0001193125-25-281562.md) | [(2.0) d](/filings/0001193125-26-131874.md) | [6.5](/filings/0001193125-26-224203.md) | [(0.3)](/filings/0001193125-26-347885.md) |
| Interest expense | $m | [0.3](/filings/0001213900-24-098550.md) | [0.2 d](/filings/0000950170-25-049918.md) | [0.3](/filings/0000950170-25-072750.md) | [0.4](/filings/0000950170-25-108424.md) | [0.4](/filings/0001193125-25-281562.md) | [0.8 d](/filings/0001193125-26-131874.md) | [1.3](/filings/0001193125-26-224203.md) | [0.8](/filings/0001193125-26-347885.md) | [0.9](/filings/0001193125-25-281562.md) | [0.3 d](/filings/0001193125-26-131874.md) | [0.2](/filings/0001193125-26-224203.md) | [0.2](/filings/0001193125-26-347885.md) |
| Income tax | $m | [(0.0)](/filings/0001213900-24-098550.md) | [(0.3) d](/filings/0000950170-25-049918.md) | [(0.0)](/filings/0000950170-25-072750.md) | [0.0](/filings/0000950170-25-108424.md) | [0.0](/filings/0001193125-25-281562.md) | [0.0 d](/filings/0001193125-26-131874.md) | [(0.0)](/filings/0001193125-26-224203.md) | [0.0](/filings/0001193125-26-347885.md) | [(0.0)](/filings/0001193125-25-281562.md) | [(0.0) d](/filings/0001193125-26-131874.md) | [0.0](/filings/0001193125-26-224203.md) | [0.0](/filings/0001193125-26-347885.md) |
| Net income | $m | [4.3](/filings/0001213900-24-098550.md) | [(47.6)](/filings/0001213900-24-036854.md) | [114](/filings/0001193125-25-281562.md) | [8.0](/filings/0001193125-25-281562.md) | [39.3](/filings/0001193125-25-281562.md) | [(11.9) d](/filings/0001193125-26-131874.md) | [(3.6)](/filings/0001193125-26-224203.md) | [11.2](/filings/0001193125-26-347885.md) | [(10.4)](/filings/0001193125-25-281562.md) | [(0.3) d](/filings/0001193125-26-131874.md) | [3.1](/filings/0001193125-26-224203.md) | [(0.2)](/filings/0001193125-26-347885.md) |
| Diluted EPS | $ per share | not reported | not reported | [1.27](/filings/0000950170-25-072750.md) | [0.00](/filings/0000950170-25-108424.md) | [0.39](/filings/0001193125-25-281562.md) | not reported | [(0.13)](/filings/0001193125-26-224203.md) | [0.30](/filings/0001193125-26-347885.md) | [(0.13)](/filings/0001193125-25-281562.md) | not reported | [0.05](/filings/0001193125-26-224203.md) | [(0.01)](/filings/0001193125-26-347885.md) |
| Basic EPS | $ per share | not reported | [(6.71)](/filings/0001213900-24-036854.md) | [1.59](/filings/0000950170-25-072750.md) | [0.10](/filings/0000950170-25-108424.md) | [0.49](/filings/0001193125-25-281562.md) | not reported | [(0.10)](/filings/0001193125-26-224203.md) | [0.30](/filings/0001193125-26-347885.md) | [(0.13)](/filings/0001193125-25-281562.md) | not reported | [0.05](/filings/0001193125-26-224203.md) | [(0.01)](/filings/0001193125-26-347885.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss, us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic, us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [0.7](/filings/0000950170-25-049918.md) | [1.1](/filings/0001213900-24-044383.md) | [1.7](/filings/0001213900-24-068376.md) | [0.8](/filings/0001213900-24-098550.md) | [0.8](/filings/0001193125-26-131874.md) | [1.1](/filings/0000950170-25-072750.md) | [26.1](/filings/0000950170-25-108424.md) | [4.3](/filings/0001193125-25-281562.md) | [1.9](/filings/0001193125-26-347885.md) | [1.2](/filings/0001193125-26-224203.md) | [3.1](/filings/0001193125-26-347885.md) |
| Current assets | $m | not reported | [2.4](/filings/0000950170-25-049918.md) | [6.1](/filings/0001213900-24-044383.md) | [2.8](/filings/0001213900-24-068376.md) | [2.1](/filings/0001213900-24-098550.md) | [4.1](/filings/0001193125-26-131874.md) | [2.7](/filings/0000950170-25-072750.md) | [28.5](/filings/0000950170-25-108424.md) | [11.9](/filings/0001193125-25-281562.md) | [10.4](/filings/0001193125-26-347885.md) | [10.5](/filings/0001193125-26-224203.md) | [16.1](/filings/0001193125-26-347885.md) |
| Total assets | $m | not reported | [63.4](/filings/0000950170-25-049918.md) | [67.8](/filings/0001213900-24-044383.md) | [65.9](/filings/0001213900-24-068376.md) | [66.6](/filings/0001213900-24-098550.md) | [61.2](/filings/0001193125-26-131874.md) | [56.7](/filings/0000950170-25-072750.md) | [89.2](/filings/0000950170-25-108424.md) | [66.8](/filings/0001193125-25-281562.md) | [66.7](/filings/0001193125-26-347885.md) | [62.4](/filings/0001193125-26-224203.md) | [63.6](/filings/0001193125-26-347885.md) |
| Current liabilities | $m | not reported | [214](/filings/0000950170-25-049918.md) | [198](/filings/0001213900-24-044383.md) | [117](/filings/0001213900-24-068376.md) | [39.4](/filings/0001213900-24-098550.md) | [45.6](/filings/0001193125-26-131874.md) | [52.1](/filings/0000950170-25-072750.md) | [56.0](/filings/0000950170-25-108424.md) | [38.9](/filings/0001193125-25-281562.md) | [28.5](/filings/0001193125-26-347885.md) | [23.4](/filings/0001193125-26-224203.md) | [24.5](/filings/0001193125-26-347885.md) |
| Total liabilities | $m | not reported | [552](/filings/0000950170-25-049918.md) | [442](/filings/0001213900-24-044383.md) | [365](/filings/0001213900-24-068376.md) | [76.0](/filings/0001213900-24-098550.md) | [81.3](/filings/0001193125-26-131874.md) | [82.7](/filings/0000950170-25-072750.md) | [88.3](/filings/0000950170-25-108424.md) | [47.0](/filings/0001193125-25-281562.md) | [42.9](/filings/0001193125-26-347885.md) | [32.7](/filings/0001193125-26-224203.md) | [33.7](/filings/0001193125-26-347885.md) |
| Long-term debt | $m | not reported | [23.0](/filings/0000950170-25-049918.md) | [20.5](/filings/0001213900-24-044383.md) | [19.9](/filings/0001213900-24-068376.md) | [25.5](/filings/0001213900-24-098550.md) | [31.0](/filings/0001193125-26-131874.md) | [30.6](/filings/0000950170-25-072750.md) | [30.2](/filings/0000950170-25-108424.md) | [6.0](/filings/0001193125-25-281562.md) | [12.5](/filings/0001193125-26-347885.md) | [7.5](/filings/0001193125-26-224203.md) | [7.6](/filings/0001193125-26-347885.md) |
| Current portion of debt | $m | [4.8](/filings/0001213900-23-087097.md) | [6.7](/filings/0000950170-25-049918.md) | [6.7](/filings/0001213900-24-044383.md) | [7.2](/filings/0001213900-24-068376.md) | [1.9](/filings/0001213900-24-098550.md) | [1.8](/filings/0001193125-26-131874.md) | [1.9](/filings/0000950170-25-072750.md) | [2.0](/filings/0000950170-25-108424.md) | [1.9](/filings/0001193125-25-281562.md) | [1.8](/filings/0001193125-26-347885.md) | [8.5](/filings/0001193125-26-224203.md) | [8.3](/filings/0001193125-26-347885.md) |
| Short-term borrowings | $m | not reported | not reported | [8.5](/filings/0001213900-24-044383.md) | [8.5](/filings/0001213900-24-068376.md) | [8.5](/filings/0001213900-24-098550.md) | [8.5](/filings/0001193125-26-131874.md) | [8.5](/filings/0000950170-25-072750.md) | [8.5](/filings/0000950170-25-108424.md) | [8.2](/filings/0001193125-25-281562.md) | [1.4](/filings/0001193125-26-347885.md) | [0.7](/filings/0001193125-26-224203.md) | [0.6](/filings/0001193125-26-347885.md) |
| Shareholders' equity | $m | not reported | [(57.1)](/filings/0000950170-25-049918.md) | [(61.7)](/filings/0001213900-24-044383.md) | [(44.7)](/filings/0001213900-24-068376.md) | [(1.4)](/filings/0001213900-24-098550.md) | [(9.0)](/filings/0001193125-26-131874.md) | [(11.6)](/filings/0000950170-25-072750.md) | [0.4](/filings/0000950170-25-108424.md) | [9.2](/filings/0001193125-25-281562.md) | [11.9](/filings/0001193125-26-347885.md) | [14.9](/filings/0001193125-26-224203.md) | [15.1](/filings/0001193125-26-347885.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:DebtCurrent, us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(3.8) d](/filings/0001213900-24-098550.md) | [(7.0) d](/filings/0000950170-25-049918.md) | [(3.8)](/filings/0000950170-25-072750.md) | [(2.6) d](/filings/0000950170-25-108424.md) | [(2.4) d](/filings/0001193125-25-281562.md) | [(3.8) d](/filings/0001193125-26-131874.md) | [0.9](/filings/0001193125-26-224203.md) | [(7.9) d](/filings/0001193125-26-347885.md) | [(13.3) d](/filings/0001193125-25-281562.md) | [(4.3) d](/filings/0001193125-26-131874.md) | [(2.8)](/filings/0001193125-26-224203.md) | [2.4 d](/filings/0001193125-26-347885.md) |
| Capital expenditure | $m | [0.0 d](/filings/0001213900-24-098550.md) | [0.0 d](/filings/0000950170-25-049918.md) | [0.0](/filings/0000950170-25-072750.md) | [0.0 d](/filings/0000950170-25-108424.md) | [0.0 d](/filings/0001193125-25-281562.md) | [0.0 d](/filings/0001193125-26-131874.md) | [0.1](/filings/0001193125-26-224203.md) | [0.0 d](/filings/0001193125-26-347885.md) | [0.0 d](/filings/0001193125-25-281562.md) | [0.0 d](/filings/0001193125-26-131874.md) | [0.0](/filings/0001193125-26-224203.md) | [0.0 d](/filings/0001193125-26-347885.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [11.1](/filings/0000950170-25-072750.md) | [12.1](/filings/0000950170-25-108424.md) | [12.3](/filings/0001193125-25-281562.md) | [37.5](/filings/0001193125-26-224203.md) | [37.5](/filings/0001193125-26-347885.md) | [37.5](/filings/0001193125-25-281562.md) | [49.2](/filings/0001193125-26-224203.md) | [49.3](/filings/0001193125-26-347885.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.